These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1345862)

  • 1. In-vitro activity of zidovudine against mycoplasma.
    Lafeuillade A; Papierok G; Pautrat G; Escarguel C; Pellegrino P; Quilichini R
    Lancet; 1992 Jan; 339(8785):131. PubMed ID: 1345862
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
    Waites KB; Reddy NB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of zidovudine, zalcitabine, and didanosine against mycoplasmas.
    Ostashewski PM; Houston SC; Robertson JA
    Lancet; 1993 Nov; 342(8881):1242-3. PubMed ID: 7901563
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of mycoplasmas to antimicrobial agents: clinical implications.
    McCormack WM
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S200-1. PubMed ID: 8399916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of Mycoplasma and its antibodies in the blood of HIV-positive patients and in healthy persons].
    Rakovskaia IV; Goncharova SA; Sarkisian NA; Miller GG
    Vestn Ross Akad Med Nauk; 1992; (9-10):41-3. PubMed ID: 1283719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasmas in HIV-1 seropositive patients.
    Bebear C; de Barbeyrac B; Clerc MT; Renaudin H; Fleury HJ; Dupon M; Ragnaud JM; Morlat P
    Lancet; 1993 Mar; 341(8847):758-9. PubMed ID: 8095655
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro activity of zidovudine against Mycoplasma.
    Taylor-Robinson D; Furr PM
    Lancet; 1992 Mar; 339(8794):686-7. PubMed ID: 1347383
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of zidovudine against mycoplasma.
    Papierok G; Lafeuillade A; Dombrecht S; Pautrat G; Pellegrino P; Escarguel C; Quilichini R
    Lancet; 1992 Dec 19-26; 340(8834-8835):1543. PubMed ID: 1361623
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of activity of zidovudine against Ureaplasma urealyticum and Mycoplasma hominis.
    Madoff S; Ferraro MJ; Merrill DP; Hirsch MS
    Lancet; 1992 Aug; 340(8817):484. PubMed ID: 1354810
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimycoplasmal activity of hydroxytyrosol.
    Furneri PM; Piperno A; Sajia A; Bisignano G
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4892-4. PubMed ID: 15561875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil.
    Furneri PM; Paolino D; Saija A; Marino A; Bisignano G
    J Antimicrob Chemother; 2006 Sep; 58(3):706-7. PubMed ID: 16787951
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy.
    Dimitrov DH; Hollinger FB; Baker CJ; Kline MW; Doyle M; Bremer JW; Shearer WT
    J Infect Dis; 1993 Apr; 167(4):818-23. PubMed ID: 8450246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on the possible origin of Mycoplasma fermentans incognitus strain based on antibiotic sensitivity tests.
    Hannan PC
    J Antimicrob Chemother; 1997 Jan; 39(1):25-30. PubMed ID: 9044024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association of disseminated Mycoplasma fermentans in HIV-1 positive patients with non-Hodgkin's lymphoma.
    Ainsworth JG; Easterbrook PJ; Clarke J; Gilroy CB; Taylor-Robinson D
    Int J STD AIDS; 2001 Aug; 12(8):499-504. PubMed ID: 11487389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro.
    Hannan PC
    J Med Microbiol; 1995 Jun; 42(6):421-8. PubMed ID: 7791207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial properties of azidothymidine (AZT).
    Monno R; Marcuccio L; Valenza MA; Leone E; Bitetto C; Larocca A; Maggi P; Quarto M
    Acta Microbiol Immunol Hung; 1997; 44(2):165-71. PubMed ID: 9330665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
    Shimizu T; Kida Y; Kuwano K
    Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type 1-infected patients.
    Dawson MS; Hayes MM; Wang RY; Armstrong D; Kundsin RB; Lo SC
    Arch Pathol Lab Med; 1993 May; 117(5):511-4. PubMed ID: 8489341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood.
    Hawkins RE; Rickman LS; Vermund SH; Carl M
    J Infect Dis; 1992 Mar; 165(3):581-5. PubMed ID: 1538164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.